» Articles » PMID: 8586467

Molecular Pathways in the Formation of Gliomas

Overview
Journal Glia
Specialty Neurology
Date 1995 Nov 1
PMID 8586467
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The past few years have seen remarkable progress in understanding the molecular genetic basis of glioma formation. Affected oncogenes and tumor suppressor genes have been identified and putative tumor suppressor loci have been mapped. These studies have illustrated distinct molecular pathways for different glial neoplasms. We summarize the findings of an ongoing study initiated to characterize human gliomas on a molecular basis. The data are compiled from 150 astrocytic, oligodendroglial, and mixed gliomas that were assessed for genomic alterations characteristic of these neoplasms, i.e., loss of portions of chromosomes 1p, 9p, 10, 17p, 17q, and 19q, mutations of the p53 tumor suppressor gene, and amplification of the EGF receptor (EGFR) gene. Our findings support the hypothesis that distinct genetic pathways result in the formation of astrocytic and oligodendroglial neoplasms of different malignancy grades, and that glioblastoma multiforme may be subdivided into genetically distinct subsets. Such findings may not only lead to a better understanding of neoplastic transformation in glial cells, but may also have a major impact on clinical neuro-oncology.

Citing Articles

Extracellular Regucalcin: A Potent Suppressor in the Cancer Cell Microenvironment.

Yamaguchi M Cancers (Basel). 2025; 17(2).

PMID: 39858022 PMC: 11763602. DOI: 10.3390/cancers17020240.


P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas.

Vij M, Cho B, Yokoda R, Rashidipour O, Umphlett M, Richardson T Acta Neuropathol Commun. 2023; 11(1):73.

PMID: 37138345 PMC: 10155323. DOI: 10.1186/s40478-023-01573-2.


Frequency and Prognosis of Epidermal Growth Factor Receptor Variant III Mutations in Glioblastoma Multiforme among Indian Patients: A Single-Institution Study.

Jose W, Munirathnam V, Narendranath V, Philip A, Keechilat P South Asian J Cancer. 2021; 9(3):126-129.

PMID: 33937133 PMC: 8075623. DOI: 10.1055/s-0041-1723078.


Long noncoding RNA FTX is upregulated in gliomas and promotes proliferation and invasion of glioma cells by negatively regulating miR-342-3p.

Zhang W, Bi Y, Li J, Peng F, Li H, Li C Lab Invest. 2017; 97(4):447-457.

PMID: 28112756 DOI: 10.1038/labinvest.2016.152.


FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.

Durmaz A, Henderson T, Brubaker D, Bebek G Pac Symp Biocomput. 2016; 22:402-413.

PMID: 27896993 PMC: 6029858. DOI: 10.1142/9789813207813_0038.